2. As of noon trading, Bristol-Myers Squibb Company ( BMY) is up $0.20 (0.5%) to $39.08 on light volume Thus far, 3.3 million shares of Bristol-Myers Squibb Company exchanged hands as compared to its average daily volume of 9.3 million shares. The stock has ranged in price between $38.85-$39.25 after having opened the day at $38.94 as compared to the previous trading day's close of $38.88.

Bristol-Myers Squibb Company, a biopharmaceutical company, discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products that help patients prevail over serious diseases worldwide. Bristol-Myers Squibb Company has a market cap of $63.8 billion and is part of the drugs industry. The company has a P/E ratio of 33.6, above the S&P 500 P/E ratio of 17.7. Shares are up 19.3% year to date as of the close of trading on Monday. Currently there are 7 analysts that rate Bristol-Myers Squibb Company a buy, 1 analyst rates it a sell, and 13 rate it a hold.

TheStreet Ratings rates Bristol-Myers Squibb Company as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, solid stock price performance, growth in earnings per share, largely solid financial position with reasonable debt levels by most measures and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Bristol-Myers Squibb Company Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you liked this article you might like

Follow the Crucial '$20 Level Rule' When Trading Stocks

$20 Should Be Your Cutoff Point

Short the Stocks That Fall Below $20

One of the Most Recognized Hedge Fund Managers Has Had a Terrible Year

Beleaguered Hedge Fund Titan Bill Ackman Is Having Another Rough Year